Head-to-head · WeighScore
Tuyo Health vs Vitara RX
By GLP-1 ScorecardUpdated
Score comparison
Vitara RX has the higher recorded score — 86/100 to 72.5/100.
Vitara RX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded GLP-1 marketplace with conflicting advertised prices and unresolved shipping-policy details.
Before you choose
Before comparing the headline prices, the Tuyo Health review and the Vitara RX review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Tuyo Health vs Zappy Health and UR Meds vs Vitara RX compare each of them with another graded program, and the list of alternatives to Tuyo Health ranks the programs closest to Tuyo Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the bmiMD review covers one graded close to these two, at 79.2/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Tuyo Health | Vitara RX |
|---|---|---|
| WeighScore | 72.5/100 | 86/100 |
| Grade | C | B |
| Site position | #88 | #10 |
| Semaglutide | GLP-1 plans from $155/mo; confirm the selected drug and renewal | Advertised from $99/month with an annual plan and discount code ($279 reference); conflicting displays—confirm selected charge. |
| Tirzepatide | Drug-specific price not disclosed | Advertised from $198/month with an annual plan and discount code ($389 reference); conflicting displays—confirm selected charge. |
| Coverage | Confirm treatment-specific availability | Site lists 49 states, Alaska omitted; confirm medication-specific availability |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
FDAWarning letter issued to Tuyo Health, Inc. dba Tuyo Health in September 2025. See the FDA warning-letter database.
Strengths
- Public terms explain the renewal cancellation deadline and participating-pharmacy billing
What to consider
- Public starting figure does not establish a medication-specific price or refill schedule
- Assigned pharmacy and coverage depend on the selected plan
- FDA issued Tuyo Health, Inc. dba Tuyo Health a warning letter in September 2025; the letter is public in FDA's warning-letter database
Strengths
- Named compounded semaglutide and tirzepatide offerings
- Ongoing provider messaging advertised
- Terms allow directing prescriptions to another pharmacy
What to consider
- Prices changed with a November site rebuild; annual-plan and discount-code conditions need confirming
- FAQ, terms and returns pages cited earlier no longer load
- Published list omitted Alaska
- Refrigeration instructions conflict with the returns policy
- No universal lab schedule or testing price established
- Website policy descriptions leave clinical and dispensing roles unclear
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.